Minnesota Becomes Second State to Adopt Newborn Screening for SMA

Leave a Comment / Advocacy, Front Page News, Our Impact /

On December 27, the Minnesota Commissioner of Health accepted the recommendation of the state’s Advisory Committee on Heritable and Congenital Disorders to add SMA to Minnesota’s newborn screening panel. With this decision, Minnesota becomes the second state, after Missouri, to adopt permanent newborn screening for SMA. Cure SMA will also be working with an implementation […]

Minnesota Becomes Second State to Adopt Newborn Screening for SMA Read More »

Cure SMA Announces Funding for Care Centers Across the US

Leave a Comment / Front Page News, Research, Support & Care /

Cure SMA is pleased to announce the first grants from $450,000 in funding to help increase capacity at SMA treatment sites across the US. In order to increase the number of affected individuals that sites can follow, treat and evaluate, Cure SMA will award $50,000 grants to nine sites, for a total of $450,000 in

Cure SMA Announces Funding for Care Centers Across the US Read More »

Biogen and Ionis Enter Into New Collaboration to Identify Novel Therapies for the Treatment of Spinal Muscular Atrophy

Leave a Comment / Front Page News, Our Impact, Research /

Biogen and Ionis Pharmaceuticals announced that they have entered into a new collaboration agreement to identify new antisense oligonucleotide drug candidates for the treatment of spinal muscular atrophy (SMA). Biogen will have the option to license therapies arising out of this collaboration and will be responsible for their development and commercialization. “We are pleased to

Biogen and Ionis Enter Into New Collaboration to Identify Novel Therapies for the Treatment of Spinal Muscular Atrophy Read More »

Cure SMA Assists Hundreds of Families in 2017

Leave a Comment / Front Page News, Our Impact, Support & Care /

Each year, Cure SMA provides thousands of families with vital support and resources to help them live active, engaged and hopeful lives. Our programs provide tangible support for families affected by SMA, easing the difficulties of an SMA diagnosis, and showing each family that they are not alone and that there is hope. Our family

Cure SMA Assists Hundreds of Families in 2017 Read More »

Miller McNeil Woodruff Foundation Awards Cure SMA Generous Gift

Leave a Comment / Community Awareness, Front Page News, Support & Care /

The Miller McNeil Woodruff Foundation recently awarded $87,000 to Cure SMA, in order to further research that will lead to treatments for all ages, stages and types of SMA. Their gift will also help fund continued advocacy and awareness initiatives. The generous donation is made each year by Patrick and Meredith Woodruff, in honor of

Miller McNeil Woodruff Foundation Awards Cure SMA Generous Gift Read More »

Cure SMA Statement on Tax Reform Bill and the Repeal of the Individual Mandate

Leave a Comment / Uncategorized /

On Wednesday, Congress passed the most sweeping tax bill in a generation. Cure SMA has been monitoring and advocating on your behalf as this legislation went through the Congress. We are happy to share that: Tax credits for rare disease drugs are saved. Cure SMA partnered with other rare disease groups to save a tax

Cure SMA Statement on Tax Reform Bill and the Repeal of the Individual Mandate Read More »

Fall 2017 Directions Now Available for Download

Leave a Comment / Community Awareness, Front Page News, Support & Care /

The Fall 2017 issue of Directions is now available. Please visit our Support & Care Publications page to download this issue or past issues of Directions. Our biannual newsletter builds our community by sharing stories and experiences. Families from all over the world connect with each other through Cure SMA to organize, share stories, photos,

Fall 2017 Directions Now Available for Download Read More »

Cure SMA Advocates Continue to Advance Newborn Screening Efforts

Leave a Comment / Advocacy, Community Awareness, Front Page News /

SMA advocates across the country are working tirelessly with Cure SMA to educate state decision makers on newborn screening. In Maryland and Minnesota, the states’ Newborn Screening Advisory Committees voted to approve a recommendation to add SMA to the state panel. We now await final approval by both states’ Commissioners of Health. Illinois, Ohio and

Cure SMA Advocates Continue to Advance Newborn Screening Efforts Read More »

AveXis Announces Plan to Initiate Phase 1 Trial in SMA Type 2 Utilizing Intrathecal Delivery of AVXS-101

Leave a Comment / Clinical Trials, Front Page News, Research /

AveXis, Inc., a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, today announced the U.S. Food and Drug Administration (FDA) has notified the company that, based on review of data submitted, the company may initiate its planned Phase 1 clinical trial of AVXS-101 for patients with spinal

AveXis Announces Plan to Initiate Phase 1 Trial in SMA Type 2 Utilizing Intrathecal Delivery of AVXS-101 Read More »

Scroll to Top